Modular Solutions

Each Beacon Solution is designed specifically to focus on one therapeutic class. Our sector specialist analysts curate preclinical and clinical data to remove ambiguity and create an unrivalled depth of accuracy and analysis.

Clinical Intelligence

Beacon analysts work together with the scientific community to identify the most relevant trends in the targeted therapy landscape and provide you with cutting-edge reports to stay ahead in a rapidly evolving environment.

Dedicated & Expert Analysts

Gain access to personalized consultations with our analysts specific to your project needs. Beacon analysts also maintain regular conversations with key opinion leaders in the sector to enable you to make the most of your clinical strategy.

Tailor your package

Adoptive Cell
Cancer Vaccine
Gene Therapy
Oncolytic Viruses
Beacon ADC Logo


Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

Beacon Adoptive Cell Logo


Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

Beacon Bispecific Logo


Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021


Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

Beacon Checkpoint Logo


Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more


Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon DDR Logo


Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

Beacon Gene Therapy Logo


From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used – Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more


Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape.

Find out more

Beacon Oncolytic Viruses Logo


From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more


Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon TPD Logo


Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more


Browse Our Database Solutions

Explore what we cover and how they can work to answer your drug development questions or solve a business need‭.‬

View here


Download our Brochure

Find out more about how Beacon can assist you in answering your business needs.

Download brochure



Find out what the key trends and changes are with our latest infographics and blogs with data sampled from our monthly modular reports.

View blog


Sign up for our free newsletters

Get the latest stories of the week in short excerpts and how Beacon is tracking this news.  Weekly and straight to your inbox.

Sign up now

What our customers say

“I look forward to using Beacon. It saves me hours of trawling through false positive results to my searches.”

Head of Competitive Intelligence
Multinational Pharmaceutical Company

“I’ve rarely seen such dedication from a service provider in understanding and responding to our needs.”

Competitive Intelligence Manager
Top 20 Pharma

Our latest content

Adoptive Cell: AACR Annual Meeting 2023 Abstracts

Find out more
The 2022 Cytokine Landscape Review series

The 2022 Cytokine Landscape Review

Find out more
The 2022 Checkpoint Landscape Review: The 2022 Drug Landscape series

The 2022 Checkpoint Landscape Review

Find out more